Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus- Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.